Biotechnology in Growth Regulation -

Biotechnology in Growth Regulation (eBook)

eBook Download: PDF | EPUB
2013 | 1. Auflage
296 Seiten
Elsevier Science (Verlag)
978-1-4831-0083-8 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
54,95 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Biotechnology in Growth Regulation
Biotechnology in Growth Regulation focuses on mechanisms of action of growth hormones and how immunological and transgenic procedures can affect growth response. The book first examines species specificity and structure-function relationship of growth hormones. Microheterogeneity of growth hormones; variations in amino acid sequence and biological properties of growth hormones; and structure-function relationship are discussed. The text also looks at growth hormone receptors and binding proteins; regulation of growth hormone receptors; modulations of growth hormone release; and neuroregulation of growth hormone secretion. The book then discusses the role of growth hormones in the regulation of adipocyte growth and function. Chronic effects of growth hormones on insulin action and lipid synthesis; effects of growth hormones on lipolysis; and adipogenesis are also described. The text looks at growth-promoting properties of recombinant growth hormones and mechanisms by which porcine growth hormone enhances growth in pigs. The book also highlights the direct effects of growth hormones on osteogenesis and chondrogenesis; action of IGF-I on mammary function; antigen-antibody complexes that enhance growth; and transgenics. The text also presents experiments that show the effects of growth hormones on animals. The book is a good source of information for readers wanting to study growth hormones.

Front Cover 1
Biotechnology in Growth Regulation 4
Copyright Page 5
PREFACE 6
LIST OF SPONSORS 7
Table of Content 8
Part 1. GROWTH HORMONE 12
Chapter 1. SPECIES SPECIFICITY AND STRUCTURE-FUNCTION RELATIONSHIPS OF GROWTH HORMONE 14
INTRODUCTION 14
MICROHETEROGENEITY OF GROWTH HORMONE 14
SPECIES SPECIFICITY OF GROWTH HORMONES: VARIATIONS IN AMINO ACID SEQUENCE 14
SPECIES SPECIFICITY OF GROWTH HORMONES: VARIATIONS IN BIOLOGICAL PROPERTIES 18
STRUCTURE-FUNCTION RELATIONSHIPS 18
CONCLUSIONS 21
REFERENCES 21
Chapter 2. GROWTH HORMONE RECEPTORS AND BINDING PROTEINS 26
INTRODUCTION 26
RECEPTOR PURIFICATION AND CLONING 27
SERUM BINDING PROTEIN 29
HOMOLOGY WITH THE PROLACTIN RECEPTOR 31
PROSPECTIVE 32
ACKNOWLEDGEMENTS 32
REFERENCES 33
Chapter 3. THE REGULATION OF THE GROWTH HORMONE RECEPTOR 38
INTRODUCTION 38
HETEROGENEITY OF THE GH RECEPTOR 38
ONTOGENY OF GH RECEPTORS 39
ENDOCRINE AND METABOLIC REGULATION OF THE GH RECEPTOR 40
CONCLUDING REMARKS 42
ACKNOWLEDGEMENTS 42
REFERENCES 42
Chapter 4. MODULATION OF GROWTH HORMONE RELEASE: FROM CNS TO THE SECRETORY EVENT 46
INTRODUCTION 46
GHRH AND SS IN THE HYPOTHALAMUS 46
OTHER HYPOTHALAMIC FACTORS INFLUENCING GH RELEASE 46
CONTROL OF HYPOTHALAMIC PEPTIDES 47
EPISODIC GH RELEASE 49
SOMATOTROPHS, SECOND MESSENGERS AND ION CHANNELS 50
GHRH CONTROL OF GH RELEASE 50
SS CONTROL OF GH RELEASE 52
INTERRELATIONSHIPS BETWEEN GH SECRETING FACTORS 52
CODA 53
ACKNOWLEDGEMENTS 53
REFERENCES 53
Chapter 5. NEUROREGULATION OF GROWTH HORMONE SECRETION 58
INTRODUCTION 58
PEPTIDERGIC CONTROL OF GH RELEASE 59
FEEDBACK PATHWAYS AND CHOLINERGIC CONTROL 61
REFERENCES 64
Chapter 6. ROLE OF GROWTH HORMONE IN THE REGULATION OF ADIPOCYTEGROWTH AND FUNCTION 68
INTRODUCTION 68
RECEPTORS FOR GH AND IGFs 68
CHRONIC EFFECTS OF GH ON INSULIN ACTION AND LIPID SYNTHESIS 69
ACUTE, INSULIN-LIKE EFFECTS OF GH ON ADIPOCYTE METABOLISM 71
EFFECTS OF GH ON LIPOLYSIS 72
MEDIATION BY IGFs 73
ADIPOGENESIS 74
CONCLUSIONS 75
REFERENCES 75
Chapter 7. A COMPARISON OF THE MECHANISMS OF ACTION OF BOVINE PITUITARY-DERIVED AND RECOMBINANT SOMATOTROPIN (ST)IN INDUCING GALACTOPOIESIS IN THE COW DURING LATELACTATION 84
INTRODUCTION 84
EXPERIMENTAL 84
RESULTS AND DISCUSSION 86
COMMENT 88
ACKNOWLEDGEMENTS 92
REFERENCES 93
Chapter 8. GROWTH PROMOTING PROPERTIES OF RECOMBINANT GROWTH HORMONE 96
INTRODUCTION 96
THE PHYSIOLOGICAL ROLE OF ENDOGENOUS GH 96
EXOGENOUS GH: GROWTH AND BODY COMPOSITION 96
THE INTERACTION BETWEEN GH AND OTHER ANABOLIC HORMONES 98
THE EFFECTS OF GH ON METABOLISM BY SPECIFIC TISSUES 99
VARIABILITY OF RESPONSIVENESS TO EXOGENOUS GH 103
CONCLUSIONS: THE FUTURE 104
ACKNOWLEDGEMENTS 105
REFERENCES 105
Chapter 9. THE MECHANISMS BY WHICH PORCINE GROWTH HORMONE IMPROVES PIG GROWTH PERFORMANCE 108
INTRODUCTION 108
METABOLIC EFFECTS OF pGH 110
SOMATOGENIC EFFECTS OF pGH 112
SUMMARY 113
REFERENCES 114
Chapter 10. EVALUATION OF SOMETRIBOVE (METHIONYL BOVINE SOMATOTROPIN) IN TOXICOLOGY AND CLINICAL TRIALS IN EUROPE AND THEUNITED STATES 118
INTRODUCTION 118
TOXICOLOGY EXPERIMENTS 118
CLINICAL TESTING 121
FARM TRIALS 123
SOMETRIBOVE AND THE DETECTION OF TREATED COWS 126
CONCLUSION 126
REFERENCES 126
Part 2. 
128 
Chapter 11. GROWTH PROMOTION USING RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I 130
INTRODUCTION 130
HYPOPHYSECTOMIZED RATS 130
YOUNG MINI-POODLES 132
SUMMARY AND CONCLUSIONS 132
REFERENCES 133
Chapter 12. THE DIRECT EFFECTS OF GROWTH HORMONE ON CHONDROGENESIS AND OSTEOGENESIS 134
INTRODUCTION 134
MECHANISTIC THEORIES OF GH ACTION 134
GH EFFECTS ON ORGAN CULTURE OF MANDIBULAR CONDYLES 135
GH EFFECTS IN TISSUE CULTURE OF CHONDROPROGENITOR CELLS 135
GH EFFECTS ON THE OSSIFICATION FRONT 135
GH EFFECTS ON THE BONE MARROW 136
CONCLUSIONS 136
ACKNOWLEDGEMENTS 136
REFERENCES 136
Chapter 13. GROWTH PROMOTION BY GROWTH HORMONE AND INSULIN-LIKE GROWTH FACTOR-I IN THE RAT 140
INTRODUCTION 140
THE HYPOPHYSECTOMIZED RAT 140
NORMAL RATS 141
IN VIVO GROWTH-PROMOTING EFFECTS OF IGF-I 143
STUDIES WITH GENETIC MUTANTS 147
DWARF RATS 148
CONCLUDING REMARKS 149
ACKNOWLEDGEMENTS 150
REFERENCES 150
Chapter 14. ACTION OF IGF-I ON MAMMARY FUNCTION 152
INTRODUCTION 152
ROLE OF INSULIN IN MAMMARY FUNCTION 152
IGF RECEPTORS 153
ROLE OF IGF-I IN MAMMARY FUNCTION IN VIVO 154
CONCLUDING REMARKS 158
ACKNOWLEDGEMENTS 158
REFERENCES 158
Chapter 15. CHANGES IN INSULIN AND SOMATOMEDIN RECEPTORS AND UPTAKEOF INSULIN, IGF-I AND IGF-II DURING MAMMARY GROWTH,LACTOGENESIS AND LACTATION 164
BACKGROUND 164
INSULIN 164
INSULIN-LIKE GROWTH FACTOR I 166
INSULIN-LIKE GROWTH FACTOR II 170
REFERENCES 172
PARTICIPANTS 278
Part 3. IMMUNOLOGICAL ENHANCEMENT 176
Chapter 16. ANTIGEN-ANTIBODY COMPLEXES THAT ENHANCE GROWTH 178
INTRODUCTION 178
MONOCLONAL ANTIBODIES 178
GH/MAb COMPLEXES AND GROWTH 179
GH/MAb COMPLEXES AND BODY COMPOSITION 181
GH/MAb COMPLEXES AND LACTOGENIC ACTIVITY 182
GH/MAb COMPLEXES AND RECEPTOR BINDING 182
COVALENT LINKING STUDIES 183
MECHANISM OF ENHANCEMENT 185
ENHANCEMENT OF GH ACTIVITY BY ACTIVE IMMUNIZATION 186
CONCLUSIONS 186
REFERENCES 186
Part 4. TRANSGENICS 190
Chapter 17. INSERTION OF GROWTH HORMONE GENES INTO PIG EMBRYOS 192
INTRODUCTION 192
INTEGRATION OF FUSION GENES 193
EXPRESSION OF INTEGRATED GENES 193
PERFORMANCE AND PHYSIOLOGICAL CHARACTERISTICS 195
TRANSMISSION OF TRANSGENES 197
CONCLUSIONS 197
REFERENCES 197
Chapter 18. INDUCED EXPRESSION OF A BOVINE GROWTH HORMONE CONSTRUCT INTRANSGENIC PIGS 200
INTRODUCTION 200
PRODUCTION OF TRANSGENIC PIGS 201
INTEGRATION OF TRANSGENE 201
EXPRESSION OF TRANSGENE 202
INDUCED EXPRESSION 202
COMMENT 205
REFERENCES 209
Part 5. ACCEPTABILITY OFBIOTECHNOLOGY 212
Chapter 19. CRITERIA FOR THE PUBLIC ACCEPTABILITY OF BIOTECHNOLOGICAL INNOVATIONS IN ANIMAL PRODUCTION 214
INTRODUCTION 214
CATEGORIES OF SOCIETY 214
PHYSIOLOGICAL CRITERIA 215
PROCEDURAL CRITERIA 216
RECOMMENDATIONS 220
CODA 220
REFERENCES 221
Part 6. POSTERS 224
Chapter 20. INDEX OF POSTERS 226
Chapter 21. STRUCTURE AND REGULATION OF THE RAT GROWTH HORMONE RECEPTOR 232
REFERENCE 232
Chapter 22. CLONING AND ANALYSIS OF EXPRESSION OF RAT GROWTH HORMONER ECEPTOR 233
Chapter 23. CONFORMATIONAL ANALYSIS OF BOVINE GROWTH HORMONE FRAGMENTS WHICH CORRESPOND TO HELICAL REGIONS OFTHE INTACT PROTEIN 233
REFERENCES 233
Chapter 24. BIOLOGICAL ACTIVITY OF AMINO-TERMINAL AMINO ACID VARIANTS OF BOVINE SOMATOTROPIN 234
REFERENCES 234
Chapter 25. PURIFICATION AND PROPERTIES OF TWO RECOMBINANT DNA-DERIVEDOVINE GROWTH HORMONE VARIANTS EXPRESSED IN ESCHERICHIA COLI 235
REFERENCES 235
Chapter 26. GH TREATMENT OF HYPOPHYSECTOMIZED RATS: HORMONE AND NUTRIENT INTERACTIONS ON TISSUE METABOLISM 236
Chapter 27. HUMAN GROWTH HORMONE TREATMENT ENHANCES DEPOSITION OFCOLLAGEN IN RAT SKELETAL MUSCLES 237
REFERENCES 237
Chapter 28. METABOLIC AND ENDOCRINE CHALLENGE OF SOMATOTROPIN TREATED PIGS 238
REFERENCES 238
Chapter 29. EFFECT OF SOMATOTROPIN ON NITROGEN AND ENERGY METABOLISM IN GROWING SWINE 239
REFERENCES 239
Chapter 30. ANTI-LIPOGENIC EFFECTS OF SOMATOTROPIN ON OVINE ADIPOSE TISSUE 240
REFERENCES 240
Chapter 31. INCREASES IN SHEEP ADIPOCYTE ß-RECEPTOR NUMBER ON EXPOSURETO GROWTH HORMONE IN VITRO 241
REFERENCES 241
Chapter 32. THE EFFECT OF GROWTH HORMONE ON HIND-LIMB MUSCLEMETABOLISM IN GROWING LAMBS 242
Chapter 33. THE EFFECT OF GROWTH HORMONE ON MUSCLE ENZYME ACTIVITYAND LACTATE DEHYDROGENASE ISOENZYME PATTERN 243
REFERENCES 243
Chapter 34. THE EFFECTS OF CLOSE-ARTERIAL INFUSION OF CIMATEROL INTO THE HIND-LIMB OF GROWING LAMBS 244
REFERENCE 244
Chapter 35. MANIPULATION OF GROWTH IN ENTIRE MALE SHEEP BY THE BETAADRENERGIC AGONIST CIMATEROL AT TWO LEVELS OF DIETARY PROTEIN 245
Chapter 36. GROWTH HORMONE RELEASE IN CALVES SELECTED FOR HIGH ANDLOW DAIRY MERIT 246
REFERENCES 246
Chapter 37. THE INFLUENCE OF BOVINE SOMATOTROPIN (BST) ON LEUKOCYTEINSULIN RECEPTORS IN LACTATING COWS AND BEEF STEERS 247
REFERENCES 247
Chapter 38. BLOOD CONSTITUENTS AND SUBCUTANEOUS ADIPOSE TISSUE METABOLISM OF DAIRY COWS AFTER ADMINISTRATION OF RECOMBINANT BOVINE SOMATOTROPIN (bST) IN A PROLONGEDRELEASE FORMULATION 248
Chapter 39. THE EFFECT OF RECOMBINANT BOVINE SOMATOTROPIN (bST) IN ASUSTAINED RELEASE VEHICLE ON THE PERFORMANCE OF DAIRY COWS 249
Chapter 40. CHANGES IN MAMMARY UPTAKE OF ESSENTIAL AMINO ACIDS INLACTATING JERSEY COWS IN RESPONSE TO EXOGENOUS BOVINEPITUITARY SOMATOTROPIN 250
REFERENCE 250
Chapter 41. BIOCHEMICAL RESPONSES TO THE USE OF RECOMBINANT BOVINE SOMATOTROPIN (SOMETRIBOVE) IN DAIRY CATTLE IN RELATIONTO PRODUCTION AND WELFARE 251
REFERENCE 251
Chapter 42. ROLE OF FEVER ON THE ENDOTOXIN-INDUCED SOMATOTROPIN RELEASE IN THE LACTATING GOAT 252
ACKNOWLEDGEMENTS 253
REFERENCES 253
Chapter 43. EFFECTS OF RECOMBINANT PORCINE GROWTH HORMONE IN GERMAN PIG BREEDS DURING GROWTH AND LACTATION 254
Chapter 44. SEMISYNTHESIS OF INSULINS WITH MODIFIED GROWTH PROMOTING PROPERTIES 255
REFERENCES 255
Chapter 45. IDENTIFICATION OF THE PORCINE INSULIN-LIKE GROWTH FACTOR(IGF)I GENE PROMOTER REGION 255
REFERENCES 256
Chapter 46. STUDIES ON THE SECRETION OF HUMAN PROINSULIN AND INSULIN-LIKE GROWTH FACTORS I AND II IN E.COLI 257
REFERENCES 257
Chapter 47. INSULIN-LIKE GROWTH FACTOR (IGF) I AND II mRNA LEVELS IN THETISSUES OF THE OVINE FETUS AND NEONATE 258
REFERENCES 258
Chapter 48. LEVELS OF INSULIN-LIKE GROWTH FACTOR I IN SHEEP TISSUES 259
REFERENCES 259
Chapter 49. MODULATION OF INSULIN-LIKE GROWTH FACTOR I AND II mRNA DURING LOCALIZED GROWTH OF RAT SKELETAL MUSCLE AND BROWN ADIPOSE TISSUE 260
REFERENCES 260
Chapter 50. IDENTIFICATION OF IGF-I mRNA IN RABBIT MAMMARY GLAND AND EVOLUTION DURING PREGNANCY AND LACTATION 261
REFERENCES 261
Chapter 51. TISSUE-SPECIFIC AND DEVELOPMENTAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-I IN THE PREGNANT AND LACTATING PIG 262
REFERENCES 262
Chapter 52. IGF-BINDING PROTEINS FROM PIG PRE-IMPLANTATION BLASTOCYSTS 263
REFERENCES 263
Chapter 53. INSULIN-DEPENDENCE OF THE SMALL IGF-BINDING PROTEIN (IGF-SBP) 264
Chapter 54. TRANSFER OF PLASMA IGF-I INTO LYMPH 265
REFERENCE 265
Chapter 55. GROWTH HORMONE (bST), INSULIN, INSULIN LIKE GROWTH FACTOR I(IGF-I) AND IGF-I BINDING PROTEINS DURING LACTATION INCATTLE 266
Chapter 56. THE EFFECT OF NUTRITIONAL STATUS AND GROWTH HORMONE (GH)TREATMENT ON THE IN VITRO MITOGENIC RESPONSES OF MAMMARY GLAND TISSUE IN LAMBS 267
Chapter 57. COMPARATIVE ASPECTS OF SELECTED HORMONES AND GROWTH FACTORS ON PROTEIN METABOLISM IN ADULT AND FETAL OVINE PRIMARY MUSCLE CULTURES 268
REFERENCE 268
Chapter 58. INDUCTION OF LACTOGENIC RECEPTORS IN HYPOPHYSECTOMIZED RATS TREATED WITH BOVINE GROWTH HORMONE-MONOCLONAL ANTIBODY COMPLEXES 269
REFERENCES 269
Chapter 59. POTENTIATION OF GROWTH HORMONE ACTIVITY USING A POLYCLONAL ANTIBODY OF RESTRICTED SPECIFICITY 270
Chapter 60. PROTEINS COVALENTLY LINKED TO HUMAN GROWTH HORMONE WILLENHANCE ITS ACTIVITY IN VIVO 271
REFERENCES 271
Chapter 61. THE EFFECT OF IMMUNONEUTRALIZATION OF CRF ON THE GROWTH OF LAMBS 272
REFERENCES 272
Chapter 62. EFFECTS OF PASSIVE IMMUNIZATION WITH AN INSULIN-LIKE GROWTH FACTOR-I (IGF-I) MONOCLONAL ANTIBODY (MAB) ON GROWTH AND PITUITARY GROWTH HORMONE (GH) CONTENT INTHE GUINEA PIG 273
Chapter 63. CONTROL OF GROWTH HORMONE SECRETION DURING GESTATION AND LACTATION IN GILTS ACTIVELY IMMUNIZED AGAINST GROWTH HORMONE-RELEASING FACTOR 274
REFERENCE 274
Chapter 64. IMMUNIZATION AGAINST GROWTH HORMONE-RELEASING FACTOR SUPPRESSES IGF-I AND ABOLISHES OPIOID AGONIST INDUCED RELEASE OF GROWTH HORMONE IN LACTATING CATTLE 275
REFERENCE 275
Chapter 65. GROWTH HORMONE EXPRESSION AND EFFECTS IN TRANSGENIC SHEEP 276
REFERENCES 276
INDEX 290

SPECIES SPECIFICITY AND STRUCTURE-FUNCTION RELATIONSHIPS OF GROWTH HORMONE


M. Wallis,     Biochemistry Laboratory, School of Biological Sciences, University of Sussex, Falmer, Brighton BN1 9QG, U.K.

Publisher Summary


This chapter describes the species specificity and structure–function relationships of growth hormone (GH). GH is a protein hormone derived from the anterior pituitary gland. It comprises a single polypeptide chain of about 190 amino acids, containing two intrachain disulfide bridges. The apparent rapid evolution of GH in the primates makes sequence studies on GH for primates other than man of particular interest. The sequence of GH from the rhesus monkey has been reported. This is very similar to that of human GH, differing at only four residues, suggesting that the rate or evolution of GH because the divergence of old-world monkeys and great apes has been slow. The implication is that GH underwent a period of remarkably rapid evolution early in primate evolution. An alternative explanation is that the primate and nonprimate GH genes are not strictly homologous, implying that a second gene is present in the human genome, homologous with nonprimate GHs and a second gene is present in the nonprimate mammalian genome, homologous with human GH. The situation is complicated by the occurrence of a cluster of GH-like genes in man.

INTRODUCTION


Growth hormone (GH) is a protein hormone derived from the anterior pituitary gland. It comprises a single polypeptide chain of about 190 amino acids, containing two intrachain disulphide bridges. In some species there is a tendency for the polypeptide chain to associate to form dimers or larger aggregates, but it is not clear whether this has any biological significance. GHs are found in all vertebrate groups except possibly the primitive, jawless fishes (Agnatha). There are considerable differences between GHs obtained from different groups, however, in both structure and biological properties.

In this paper I shall survey current knowledge about the species specificity of GHs. concentrating mainly on the differences between the primary structures for which information is available. Some aspects of the relationship between structure and function in GH will also be considered.

MICROHETEROGENEITY OF GROWTH HORMONE


Although for any one species it is normal to refer to GH as a single component, the hormone in many species is known to exist in a number of different forms. As a consequence, GH isolated from anterior pituitaries usually shows microheterogeneity. Such heterogeneity may arise from a number of causes, including the occurrence of more than one gene for the hormone, variant forms of mRNA due to different processing pathways for the mRNA precursors, allelic variation in the population of animals from which the hormone is derived, variable glycosylation (although in most species GH is not glycosylated), limited enzymic cleavage, N-terminal heterogeneity and deamidation. Heterogeneity has been most extensively studied in the case of human GH (20), but occurs in GHs from most other species also. Its physiological significance, if any, is not fully understood, but its possible importance should be borne in mind when species differences and structure-function relationships are discussed.

SPECIES SPECIFICITY OF GROWTH HORMONES: VARIATIONS IN AMINO ACID SEQUENCE


The first GH for which the amino acid sequence was reported was the human hormone (25). Subsequent work on GHs from a number of species produced the sequences of ovine, bovine, horse and pig GHs (summarized in Ref. 40) and revision of the human GH sequence. In 1977 application of the techniques of recombinant DNA allowed the sequence of rat GH to be deduced from the corresponding cDNA/mRNA nucleotide sequence (32). Since then application of both recombinant DNA techniques and conventional protein sequencing has increased the number of complete GH sequences available to at least 20 including 2 primates. 9 non-primate mammals, 2 birds, 1 amphibian and 7 teleost fish. Some of these sequences are summarized in Fig. 1; some are based on protein sequencing, some on cDNA/genomic DNA sequencing and some on both.

Fig. 1 The amino acid sequences of some tetrapod GHs (see opposite)

The availability of sequences for GHs from such a considerable number of species enables detailed comparisons to be made and assessment of possible pathways of molecular evolution in this protein-hormone family. These have been discussed previously (26, 27 41). The additional sequences that have been described in the past few years provide confirmation of the main features recognized previously, particularly with respect to apparently variable rates of evolution.

When the amino acid sequences of non-primate mammalian GHs are compared it is clear that they are very similar. However, when any of these sequences (or a consensus sequence derived from them) is compared with the sequence of human GH the difference is marked (41). The various orders of placental mammals are thought to have diverged at about the same time, 70 million years ago. The divergence time for rat and human is therefore about the same as that for rat and pig; however, rat GH differs from human GH at ∼ 35% of all residues but from pig GH at ∼ 5% of all residues. Such observations suggest that the rate of evolution of GHs in the primates has been much greater than that in non-primate mammals. A variable rate of evolution within a protein family is relatively unusual – normally it is found that the rate of evolution for any individual protein is remarkably constant (though rates vary from one protein to another; eg Ref. 16). The rate of evolution can be quantified by determining a most probable sequence for the GH of the ancestor of the placental mammals (from sequence data available for exisiting mammals) (41). This is very similar to the sequences of pig. fin whale and horse GHs (Fig. 1). The number of amino acid differences observed between the existing GH sequences and this ancestral sequence can then be used to determine the rates of evolution for GH in each of the groups concerned (Table 1).

Table 1

Rates of evolution for growth hormones

*Accepted point mutations/100 residues/108 yr

**’Placental ancestor’ represents the hypothetical GH sequence of the common ancestor of the placental mammals.

A hypothetical (best fit sequence for the GH of the common ancestor of the placental mammals (Anc. p.m.) was derived from available GH sequences, using methods described previously (41). This is shown, using one-letter code. Sequences of various tetrapod GHs are compared with this. A solid line indicates sequence identity; differences are shown using one-letter code; – indicates a gap. Note that the sequences of pig, horse and whale GHs are very similar to the ancestral sequence but those of man, chicken and bullfrog differ from it substantially. Original data for the sequences shown may be found in Refs. 32 (rat), 34 (chicken). 33 (pig). 38 (whale). 29 (bullfrog) or references cited in Ref. 41 (horse, man. ox).

The apparent rapid evolution of GH in the primates makes sequence studies on GH for primates other than man of particular interest. The sequence of GH from the rhesus monkey has been reported (23). This is very similar to that of human GH, differing at only 4 residues, suggesting that the rate of evolution of GH since the divergence of old-world monkeys and great apes (approximately 20 million years ago) has been slow. The implication is that GH underwent a period of remarkably rapid evolution early in primate evolution. An alternative explanation is that the primate and non-primate GH genes are not strictly homologous, implying that a second gene (or family of genes) is present in the human genome, homologous with non-primate GHs (but not expressed as a major form in the pituitary) and a second gene is present in the non-primate mammalian genome, homologous with human GH (but again not expressed in the pituitary). The situation is complicated by the occurrence of a cluster of GH-like genes in man (eg Ref. 12). More information is needed, especially about GH (and GH genes) in other primates. However, it is clear that the nature of GH in primates and non-primates is remarkably different and this must be taken into account when considering the biological actions of the hormone in different species.

The rate of evolution of GHs also appears to have increased, though to a less marked extent, during the evolution of the ruminants (Table 1). The sequences of sheep, ox and goat GHs have all been determined; they show marked similarities. Sequences of any of these ruminant GHs differ from the sequences of rat or pig GHs at about 11% of all residues, whereas the rat, horse, fin whale and pig hormones differ at only 1–5% of all residues.

Most previous discussion of GH evolution has concentrated on mammalian GHs. Sequences of several non-mammalian GHs are now available. In general they are fairly similar to the sequences of the non-primate mammalian GHs. Sequences of GHs from bird (chicken and duck) (5, 34) are more similar to the non-primate GHs than the latter are to human GH, confirming the very rapid evolution...

Erscheint lt. Verlag 22.10.2013
Sprache englisch
Themenwelt Sachbuch/Ratgeber Natur / Technik Naturführer
Medizin / Pharmazie
Naturwissenschaften Biologie Zoologie
ISBN-10 1-4831-0083-9 / 1483100839
ISBN-13 978-1-4831-0083-8 / 9781483100838
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 33,9 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 5,2 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Über 440 Vogelarten Europas, mehr als 1.600 Abbildungen EXTRA: Mach …

von Volker Dierschke

eBook Download (2024)
Franckh-Kosmos Verlags-GmbH & Co. KG
13,99